Ida Laurén

Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19

Sebastian Havervall, Henry Ng, August Jernbom Falk et al. · Journal of Internal Medicine · 2021 · 71 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Factors Associated With Serological Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Rituximab

Andreas Tolf, Anna Wiberg, Malin Müller et al. · JAMA Network Open · 2022 · 27 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Fed-batch production assessment of a tetravalent bispecific antibody: A case study on piggyBac stably transfected HEK293 cells

Antonino Napoleone, Ida Laurén, Triinu Linkgreim et al. · New Biotechnology · 2021 · 24 citations · Full text

Pharmacy, Bioengineering, Biotechnology +17

Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Mohamed Eltahir, Erika Fletcher, Linn Dynesius et al. · International Immunopharmacology · 2020 · 13 citations · Full text

Life Sciences, Hematology, Immunology +15

An evaluation of a FluoroSpot assay as a diagnostic tool to determine SARS-CoV-2 specific T cell responses

Sara M. Mangsbo, Sebastian Havervall, Ida Laurén et al. · PLoS ONE · 2021 · 12 citations · Full text

Life Sciences, Immunology, Infectious Diseases +13